Advertise on podcast: ASHPOfficial

This activity explores emerging evidence on the relationship between GLP-1 receptor agonists therapy and bone mineral density. As the use of these agents expands across chronic disease states, pharmacists must understand their potential impact on bone health to support comprehensive patient care and risk mitigation.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As artificial intelligence becomes embedded across health systems, pharmacy leaders face a new challenge: leading organizational change to seamlessly adopt and integrate it. Join pharmacy executives and innovation leaders as they discuss managing workforce expectations, establishing strong AI governance, measuring meaningful outcomes, and scaling successful initiatives to drive lasting value across the pharmacy enterprise.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Hannah Post, education director at ASHP, as she interviews Heidi Trinkman, advanced therapeutics program manager at Cook Children's Health Care System, Emilie Aschenbrenner, pharmacy program lead for cell and gene therapy and bone marrow transplant at Froedtert Hospital, and Wendy Galbraith, Clinical Associate Professor at the University of Oklahoma Health Sciences Center, to discuss their upcoming session: Transforming Care Through Next-Generation Therapeutics: Theranostics, Cell and Gene Therapies, and Pharmacogenomics.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a deep dive with the authors of the new ASHP Guidelines on Pharmacist Involvement in HIV Care, where we will unpack its contents. This episode discusses the evolving role of pharmacists in HIV prevention, treatment, and management, from expanding access to HIV testing and PrEP/PEP services to optimizing antiretroviral therapy and addressing social determinants of health. We’ll explore how pharmacists can improve patient outcomes and advocate for policy changes that deepen our impact. Tune in to learn what’s new, what’s next, and how these guidelines can transform HIV care across all practice settings. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Anthony Scott, director, pharmacy operations and account management at Cardinal Health, and Katherine Miller, senior director acute care pharmacy & clinical nutrition at The University of Kansas Health System, to discuss their upcoming session: Futurecasting Your Department: Strategic Succession Planning in an Era of Rapid Change. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Women experience changes in thrombotic and bleeding risk across every stage of life, yet these considerations are often underrecognized in antithrombotic management. This episode explores how antithrombotic stewardship can optimize care from menstruation through menopause, highlighting practical strategies for managing heavy menstrual bleeding, contraception, pregnancy considerations, perimenopause, and hormone therapy while balancing thrombosis and bleeding risks. Listeners will gain evidence-based approaches to individualized patient care, improve interdisciplinary collaboration, and identify stewardship opportunities to enhance safety, outcomes, and health equity for patients receiving anticoagulant and antithrombotic therapy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Advocacy is a driving force behind our strategic priorities and this year’s Policy Week brought those priorities directly to Capitol Hill. ASHP Executive Vice President and CEO Sam Calabrese and Chief Advocacy Officer and Vice President of Government Relations Tom Kraus reflect on this year’s Policy Week, discussing the key policy priorities that shaped the week, conversations with lawmakers and congressional staff, and the momentum surrounding pharmacy’s advocacy priorities. From meaningful engagement on the Hill to the collective voice of our members, we’ll explore how Policy Week is helping turn our advocacy priorities into action. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses resources and offers support for residents that have experienced a co-resident’s departure from the residency program. Discussion will involve how to re-balance and carry the mental load if residents are expected to fill in the gap.  Listeners will hear discussions from residency program directors and past residents that experienced the departure of a co-resident.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores medication access options for uninsured and underinsured patients, including manufacturer patient assistance programs, copay cards, nonprofit foundations, discount programs, and federal assistance. It also highlights how advanced pharmacy technicians lead medication access programs that improve adherence, reduce costs, streamline workflows, and drive measurable quality and financial outcomes.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Clinical trials in acute and emergency care settings may require immediate pharmacy support in the evenings, nights and weekends when staff with specialized expertise are not on site.  In this episode, two experienced clinical research pharmacists highlight the challenges of after-hours investigational drug dispensing and detail practical strategies and creative techniques for managing these time-sensitive studies.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Thomas Johnson, vice president of diagnostic and therapeutic services at Avera Health, to discuss his upcoming session: From Overlooked to Approved: The Power of Clarity with C-Suite Resource Requests.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Respiratory Syncytial Virus (RSV) is the most common cause of bronchiolitis, the most common lower respiratory tract infection in infants less than 12 months old. The recent availability of a maternal vaccination and a neonatal/infant immunoglobulin injection provide the chance for a dramatic change in the rates of infection. Unfortunately, an increasing vaccination hesitancy in the United States threatens the potential of these efforts. After completing this episode, learners will be able to discuss the presentation and management of an infant with RSV and review the vaccination processes to prevent transmission of RSV. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, a panel of expert clinicians tackle some common and challenging unanswered questions surrounding the use of buprenorphine for chronic pain. Drawing from real-world practice, they explore strategies for initiation, risk mitigation, perioperative management, and formulation selection- while addressing practical barriers and off-label approaches. Listen in for evidenced-informed insights that bridge the gap between clinical uncertainty and confident prescribing.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Michael Wolcott, assistant dean for student affairs and associate professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, to discuss his upcoming session: From Curious to Confident: A Practical Primer for Preceptors Interested in Artificial Intelligence. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Eric Tichy and Denise Scarpelli discuss the AJHP Special Feature "National trends in prescription drug expenditures and projections for 2026” with host and AJHP Editor in Chief Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.